"Acclaim Clinical Research is a dedicated research site of multi-specialty physicians, conducting Phase I-IV research studies. We are pleased to offer a highly professional research team with a proven track record in clinical trials. Our mission is to satisfy all Sponsor and CRO objectives, from delivering the highest quality data to meeting and even exceeding enrollment goals in a timely fashion."

During the past decade, Acclaim Clinical Research conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Acclaim Clinical Research" are "COVID-19" (1 trials), "Epstein-Barr Virus Infection" (1 trials), "Migraine" (1 trials), "Migraine With Aura" (1 trials) and "Migraine Without Aura" (1 trials). Many other conditions were trialed in "Acclaim Clinical Research" in a lesser frequency.

Most popular intervention types in "Acclaim Clinical Research" are "Biological" (4 trials), "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Afluria® Quadrivalent" (1 trials), "Dihydroergotamine" (1 trials), "IBI314" (1 trials) and "Licensed quadrivalent inactivated seasonal influenza vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Acclaim Clinical Research" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Acclaim Clinical Research". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Acclaim Clinical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Acclaim Clinical Research, 2 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".